Matières premières

Abbott received an emergency use authorization from the FDA for its COVID-19 diagnostic, and announced goals to ramp up U.S. production to 1 million tests per week by the end of March....

est cité dans une actualité de FierceBiotech

Il y a 1 semaine

With new FDA approval, Abbott sets goal of shipping 1 million coronavirus tests per week

Merck has linked gefapixant to statistically significant improvements in chronic cough patients in two phase 3 trials. The results cement Merck’s status as the front-runner in the race to develop a...

est cité dans une actualité de FierceBiotech

Il y a 1 semaine

Merck hits goal in cough phase 3 but yet to quash tolerability concern

Le spécialiste français des solutions de diagnostic a lancé deux programmes pour la mise au point de tests pour la détection du Covid-19, avec une... - L'Usine Santé

BIOMERIEUX

est cité dans une actualité de L'Usine Nouvelle

Le 28/02/2020

BioMérieux travaille sur deux tests de détection du coronavirus Covid-19

www.usinenouvelle.com

After 17 years at Amgen, head of R&D Sean Harper was ready to get closer to the science. He reunited with his former colleague from Merck and Amgen, Beth Seidenberg, in Los Angeles and set up...

est cité dans une actualité de FierceBiotech

Le 19/02/2020

'Closer to the science': Why Amgen vets Harper and Seidenberg set up their own VC shop

Abbott plans to launch a head-to-head study that puts its structural heart device up against a newer generation of blood thinners, testing its ability to lower the risk of strokes in people with...

est cité dans une actualité de FierceBiotech

Le 04/02/2020

Abbott to test its heart device against lifetime blood thinners for reducing stroke risk

Abbott received a CE mark for a first-of-its-kind transcatheter mitral valve implantation system, aimed at stopping leakage and backflow within the heart when open surgery or minimally invasive repair...

est cité dans une actualité de FierceBiotech

Le 31/01/2020

Abbott nets first CE mark for transcatheter mitral valve replacement

In this week's EuroBiotech Report, Roche's risdiplam clears another phase 3 SMA trial, Merck KGaA spinout raises cash and Korean VCs back PDC*line....

est cité dans une actualité de FierceBiotech

Le 24/01/2020

EuroBiotech Report—Roche SMA data, iOnctura, PDC*line, Targovax and Bayer

iOnctura, a spinout from Merck KGaA, has raised €15M to take its cancer and fibrosis drugs to phase I clinical trials. The Series A round was co-led by new investors INKEF Capital and VI Partners....

est cité dans une actualité de Labiotech.eu

Le 24/01/2020

Merck Spinout Bags €15M Series A to Tackle Cancer and Fibrosis

www.labiotech.eu

Le régulateur américain a approuvé le 9 janvier Ervebo, le vaccin contre Ebola produit par Merck. Celui-ci a déjà servi à... - Infos Reuters

est cité dans une actualité de L'Usine Nouvelle

Le 14/01/2020

Les États-Unis autorisent Ervebo, le vaccin anti-Ebola de Merck

www.usinenouvelle.com

Not long after elevating a company veteran to be its next CEO, Abbott has now done the same within its financial leadership. Robert Funck Jr. will take the place of CFO Brian Yoor after he retires at...

est cité dans une actualité de FierceBiotech

Le 10/01/2020

Abbott names new CFO shortly ahead of CEO transition